Ablation of CD8


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
27 10 2022
Historique:
received: 25 01 2022
accepted: 17 10 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 1 11 2022
Statut: epublish

Résumé

The emergence of the SARS-CoV-2 Omicron variant has raised concerns of escape from vaccine-induced immunity. A number of studies have demonstrated a reduction in antibody-mediated neutralization of the Omicron variant in vaccinated individuals. Preliminary observations have suggested that T cells are less likely to be affected by changes in Omicron. However, the complexity of human leukocyte antigen genetics and its impact upon immunodominant T cell epitope selection suggests that the maintenance of T cell immunity may not be universal. In this study, we describe the impact that changes in Omicron BA.1, BA.2 and BA.3 have on recognition by spike-specific T cells. These T cells constitute the immunodominant CD8

Identifiants

pubmed: 36302758
doi: 10.1038/s41467-022-34180-1
pii: 10.1038/s41467-022-34180-1
pmc: PMC9607807
doi:

Substances chimiques

Immunodominant Epitopes 0
Antibodies, Viral 0
Antibodies, Neutralizing 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6387

Informations de copyright

© 2022. The Author(s).

Références

Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
Nat Med. 2021 Jul;27(7):1280-1289
pubmed: 34017137
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Clin Invest. 2021 Mar 1;131(5):
pubmed: 33427749
mBio. 2022 Apr 26;13(2):e0361721
pubmed: 35229637
Int J Mol Sci. 2020 Dec 23;22(1):
pubmed: 33374673
Nat Med. 2022 Mar;28(3):472-476
pubmed: 35042228
Sci Immunol. 2021 Apr 14;6(58):
pubmed: 33853928
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
pubmed: 15299374
Immunity. 2021 May 11;54(5):1055-1065.e5
pubmed: 33945786
iScience. 2021 Feb 19;24(2):102096
pubmed: 33521593
J Synchrotron Radiat. 2018 May 1;25(Pt 3):885-891
pubmed: 29714201
Lancet. 2022 Jan 15;399(10321):234-236
pubmed: 34942101
Ann Neurol. 2022 Jan;91(1):89-100
pubmed: 34687063
Cell Rep. 2021 Sep 14;36(11):109708
pubmed: 34506741
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Cell Rep Med. 2021 Feb 16;2(2):100204
pubmed: 33521695

Auteurs

Srividhya Swaminathan (S)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.
Faculty of Medicine, The University of Queensland, Herston, QLD, 4006, Australia.

Katie E Lineburg (KE)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Archana Panikkar (A)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Jyothy Raju (J)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Lawton D Murdolo (LD)

Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.

Christopher Szeto (C)

Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.
Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.

Pauline Crooks (P)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Laetitia Le Texier (L)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Sweera Rehan (S)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Michael J Dewar-Oldis (MJ)

Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.

Peter J Barnard (PJ)

Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.

George R Ambalathingal (GR)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Michelle A Neller (MA)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Kirsty R Short (KR)

School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.

Stephanie Gras (S)

Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia.
Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.

Rajiv Khanna (R)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.
Faculty of Medicine, The University of Queensland, Herston, QLD, 4006, Australia.

Corey Smith (C)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia. corey.smith@qimrberghofer.edu.au.
Faculty of Medicine, The University of Queensland, Herston, QLD, 4006, Australia. corey.smith@qimrberghofer.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH